Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Yuki Y, Kurokawa S, Sugiura K, Kashima K, Maruyama S, Yamanoue T, Honma A, Mejima M, Takeyama N, Kuroda M, Kozuka-Hata H, Oyama M, Masumura T, Nakahashi-Ouchida R, Fujihashi K, Hiraizumi T, Goto E, Kiyono H. Yuki Y, et al. Among authors: kurokawa s. Front Plant Sci. 2024 Mar 15;15:1342662. doi: 10.3389/fpls.2024.1342662. eCollection 2024. Front Plant Sci. 2024. PMID: 38559768 Free PMC article.
Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
Yuki Y, Mejima M, Kurokawa S, Hiroiwa T, Takahashi Y, Tokuhara D, Nochi T, Katakai Y, Kuroda M, Takeyama N, Kashima K, Abe M, Chen Y, Nakanishi U, Masumura T, Takeuchi Y, Kozuka-Hata H, Shibata H, Oyama M, Tanaka K, Kiyono H. Yuki Y, et al. Among authors: kurokawa s. Plant Biotechnol J. 2013 Sep;11(7):799-808. doi: 10.1111/pbi.12071. Epub 2013 Apr 22. Plant Biotechnol J. 2013. PMID: 23601492 Free article.
Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
Sasou A, Yuki Y, Honma A, Sugiura K, Kashima K, Kozuka-Hata H, Nojima M, Oyama M, Kurokawa S, Maruyama S, Kuroda M, Tanoue S, Takamatsu N, Fujihashi K, Goto E, Kiyono H. Sasou A, et al. Among authors: kurokawa s. BMC Genomics. 2021 Jan 19;22(1):59. doi: 10.1186/s12864-020-07355-7. BMC Genomics. 2021. PMID: 33468052 Free PMC article.
Development of Antibody-Fragment-Producing Rice for Neutralization of Human Norovirus.
Sasou A, Yuki Y, Kurokawa S, Sato S, Goda Y, Uchida M, Matsumoto N, Sagara H, Watanabe Y, Kuroda M, Sakon N, Sugiura K, Nakahashi-Ouchida R, Ushijima H, Fujihashi K, Kiyono H. Sasou A, et al. Among authors: kurokawa s. Front Plant Sci. 2021 Feb 23;12:639953. doi: 10.3389/fpls.2021.639953. eCollection 2021. Front Plant Sci. 2021. PMID: 33868338 Free PMC article.
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Yuki Y, Nojima M, Kashima K, Sugiura K, Maruyama S, Kurokawa S, Yamanoue T, Nakahashi-Ouchida R, Nakajima H, Hiraizumi T, Kohno H, Goto E, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: kurokawa s. Vaccine. 2022 May 26;40(24):3372-3379. doi: 10.1016/j.vaccine.2022.04.051. Epub 2022 Apr 26. Vaccine. 2022. PMID: 35484039 Free article. Clinical Trial.
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.
Tokuhara D, Álvarez B, Mejima M, Hiroiwa T, Takahashi Y, Kurokawa S, Kuroda M, Oyama M, Kozuka-Hata H, Nochi T, Sagara H, Aladin F, Marcotte H, Frenken LG, Iturriza-Gómara M, Kiyono H, Hammarström L, Yuki Y. Tokuhara D, et al. Among authors: kurokawa s. J Clin Invest. 2013 Sep;123(9):3829-38. doi: 10.1172/JCI70266. Epub 2013 Aug 8. J Clin Invest. 2013. PMID: 23925294 Free PMC article.
518 results